塩野義薬（4507） Shionogi Announces Supplemental New Drug Application for XOFLUZA in Japan for the Post-Exposure Prophylaxis of Influenza Virus Infection was Approved.
2020/11/27
ブックマーク
メモを書く
/
-
読み込み中…
